{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:05:01Z","timestamp":1793642701845,"version":"4.5.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007772","name":"Agir pour les Maladies Chroniques","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007772","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-66210-x","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T15:15:55Z","timestamp":1725549355000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Early screening for chronic liver disease: impact of a FIB-4 first integrated care pathway to identify patients with significant fibrosis"],"prefix":"10.1038","volume":"14","author":[{"given":"V.","family":"Mignot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Chirica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Tron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Borowik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. L.","family":"Borel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Rostaing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Bouillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Decaens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Guergour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. E.","family":"Costentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"issue":"Suppl 1","key":"66210_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/liv.13682","volume":"38","author":"P Marcellin","year":"2018","unstructured":"Marcellin, P. & Kutala, B. K. Liver diseases: A major, neglected global public health problem requiring urgent actions and large-scale screening. Liver Int. 38(Suppl 1), 2\u20136 (2018).","journal-title":"Liver Int."},{"issue":"12","key":"66210_CR2","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1016\/j.cgh.2019.07.060","volume":"18","author":"AM Moon","year":"2020","unstructured":"Moon, A. M., Singal, A. G. & Tapper, E. B. Contemporary epidemiology of chronic liver disease and cirrhosis. Clin. Gastroenterol. Hepatol. 18(12), 2650\u20132666 (2020).","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"1","key":"66210_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani, S. K., Devarbhavi, H., Eaton, J. & Kamath, P. S. Burden of liver diseases in the world. J. Hepatol. 70(1), 151\u2013171 (2019).","journal-title":"J. Hepatol."},{"issue":"1","key":"66210_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64(1), 73\u201384 (2016).","journal-title":"Hepatology"},{"key":"66210_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100445","volume":"25","author":"J Boursier","year":"2020","unstructured":"Boursier, J., Shreay, S., Fabron, C., Torreton, E. & Fraysse, J. Hospitalization costs and risk of mortality in adults with nonalcoholic steatohepatitis: Analysis of a french national hospital database. EClinicalMedicine 25, 100445 (2020).","journal-title":"EClinicalMedicine"},{"issue":"7","key":"66210_CR6","first-page":"726","volume":"67","author":"N Ganne-Carri\u00e9","year":"2017","unstructured":"Ganne-Carri\u00e9, N. \u00c9pid\u00e9miologie de la cirrhose. Rev. Prat. 67(7), 726\u2013730 (2017).","journal-title":"Rev. Prat."},{"issue":"3","key":"66210_CR7","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","volume":"69","author":"L Pimpin","year":"2018","unstructured":"Pimpin, L. et al. EASL HEPAHEALTH Steering Committee. Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies. J. Hepatol. 69(3), 718\u2013735 (2018).","journal-title":"J. Hepatol."},{"issue":"1","key":"66210_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hep.29466","volume":"67","author":"C Estes","year":"2018","unstructured":"Estes, C., Razavi, H., Loomba, R., Younossi, Z. & Sanyal, A. J. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology 67(1), 123\u2013133 (2018).","journal-title":"Hepatology"},{"issue":"5","key":"66210_CR9","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/hep.29085","volume":"65","author":"PS Dulai","year":"2017","unstructured":"Dulai, P. S. et al. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis. Hepatology 65(5), 1557\u20131565 (2017).","journal-title":"Hepatology"},{"issue":"7","key":"66210_CR10","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1136\/gutjnl-2020-322786","volume":"70","author":"TG Simon","year":"2021","unstructured":"Simon, T. G., Roelstraete, B., Khalili, H., Hagstr\u00f6m, H. & Ludvigsson, J. F. Mortality in biopsy-confirmed nonalcoholic fatty liver disease: Results from a nationwide cohort. Gut. 70(7), 1375\u20131382 (2021).","journal-title":"Gut."},{"key":"66210_CR11","doi-asserted-by":"publisher","first-page":"702","DOI":"10.3109\/00365521.2012.661759","volume":"47","author":"AD Fialla","year":"2012","unstructured":"Fialla, A. D., de Muckadell, O. B. S. & Touborg Lassen, A. Incidence, etiology and mortality of cirrhosis: A population-based cohort study. Scand. J. Gastroenterol. 47, 702\u2013709 (2012).","journal-title":"Scand. J. Gastroenterol."},{"issue":"3","key":"66210_CR12","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jhep.2016.10.015","volume":"66","author":"N Goutt\u00e9","year":"2017","unstructured":"Goutt\u00e9, N. et al. Geographical variations in incidence, management and survival of hepatocellular carcinoma in a western country. J. Hepatol. 66(3), 537\u2013544 (2017).","journal-title":"J. Hepatol."},{"issue":"2","key":"66210_CR13","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jhep.2013.09.027","volume":"60","author":"S Ratib","year":"2014","unstructured":"Ratib, S., Fleming, K. M., Crooks, C. J., Aithal, G. P. & West, J. 1 and 5 year survival estimates for people with cirrhosis of the liver in england, 1998\u20132009: A large population study. J. Hepatol. 60(2), 282\u2013289 (2014).","journal-title":"J. Hepatol."},{"issue":"1","key":"66210_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","volume":"44","author":"G D'Amico","year":"2006","unstructured":"D\u2019Amico, G., Garcia-Tsao, G. & Pagliaro, L. Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies. J. Hepatol. 44(1), 217\u2013231 (2006).","journal-title":"J. Hepatol."},{"issue":"1","key":"66210_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/hep4.1018","volume":"1","author":"LC Bertot","year":"2017","unstructured":"Bertot, L. C. et al. Nonalcoholic fatty liver disease-related cirrhosis is commonly unrecognized and associated with hepatocellular carcinoma. Hepatol. Commun. 1(1), 53\u201360 (2017).","journal-title":"Hepatol. Commun."},{"issue":"7","key":"66210_CR16","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00432-004-0552-0","volume":"130","author":"BH Zhang","year":"2004","unstructured":"Zhang, B. H., Yang, B. H. & Tang, Z. Y. Randomized controlled trial of screening for hepatocellular carcinoma. J. Cancer Res. Clin. Oncol. 130(7), 417\u2013422 (2004).","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"7","key":"66210_CR17","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1038\/sj.bjc.6604301","volume":"98","author":"J Thompson Coon","year":"2008","unstructured":"Thompson Coon, J. et al. Surveillance of cirrhosis for hepatocellular carcinoma: A cost-utility analysis. Br. J. Cancer 98(7), 1166\u20131175 (2008).","journal-title":"Br. J. Cancer"},{"issue":"2","key":"66210_CR18","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1053\/j.gastro.2018.04.027","volume":"155","author":"CE Costentin","year":"2018","unstructured":"Costentin, C. E. et al. ANRS CO12 CirVir Group. Compliance with hepatocellular carcinoma surveillance guidelines associated with increased lead-time adjusted survival of patients with compensated viral cirrhosis: A multi-center cohort study. Gastroenterology 155(2), 431-442.e10 (2018).","journal-title":"Gastroenterology"},{"key":"66210_CR19","unstructured":"Institut National du Cancer. FEUILLE DE ROUTE 2021\u20132025\u2014STRAT\u00c9GIE D\u00c9CENNALE DE LUTTE CONTRE LES CANCERS 2021\u20132030 (2021). https:\/\/www.e-cancer.fr\/Institut-national-du-cancer\/Strategie-de-lutte-contre-les-cancers-en-France\/La-strategie-decennale-de-lutte-contre-les-cancers-2021-2030."},{"key":"66210_CR20","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver. Clinical Practice Guideline Panel; Chair; EASL Governing Board representative; Panel members. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis\u20142021 update. J. Hepatol. 2021;75(3):659\u2013689.","DOI":"10.1016\/j.jhep.2021.05.025"},{"issue":"6","key":"66210_CR21","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling, R. K. et al. APRICOT Clinical Investigators. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology 43(6), 1317\u201325 (2006).","journal-title":"Hepatology"},{"issue":"4","key":"66210_CR22","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E Von Elm","year":"2008","unstructured":"Von Elm, E. et al. STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. J. Clin. Epidemiol. 61(4), 344\u20139 (2008).","journal-title":"J. Clin. Epidemiol."},{"key":"66210_CR23","unstructured":"D\u00e9lib\u00e9ration n\u00b0 2018-155 du 3 mai 2018 portant homologation de la m\u00e9thodologie de r\u00e9f\u00e9rence relative aux traitements de donn\u00e9es \u00e0 caract\u00e8re personnel mis en \u0153uvre dans le cadre des recherches n'impliquant pas la personne humaine, des \u00e9tudes et \u00e9valuations dans le domaine de la sant\u00e9 (MR-004)\u2014L\u00e9gifrance (legifrance.gouv.fr) last available 22\/02\/2024."},{"issue":"5","key":"66210_CR24","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","volume":"23","author":"KG Alberti","year":"2006","unstructured":"Alberti, K. G., Zimmet, P. & Shaw, J. Metabolic syndrome\u2013a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet. Med. 23(5), 469\u2013480 (2006).","journal-title":"Diabet. Med."},{"key":"66210_CR25","unstructured":"Sant\u00e9 Publique France. Avis d'experts relatif \u00e0 l'\u00e9volution du discours public en mati\u00e8re de consommation d'alcool en France organis\u00e9 par Sant\u00e9 publique France et l'Institut national du cancer (2017). https:\/\/www.santepubliquefrance.fr\/les-actualites\/2017\/avis-d-experts-relatif-a-l-evolution-du-discours-public-en-matiere-de-consommation-d-alcool-en-france-organise-par-sante-publique-france-et-l-insti."},{"issue":"5","key":"66210_CR26","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","volume":"66","author":"T Karlas","year":"2017","unstructured":"Karlas, T. et al. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. J. Hepatol. 66(5), 1022\u20131030 (2017).","journal-title":"J. Hepatol."},{"issue":"2","key":"66210_CR27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jhep.2022.10.034","volume":"78","author":"AJ Sanyal","year":"2023","unstructured":"Sanyal, A. J. et al. Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores. J. Hepatol. 78(2), 247\u2013259 (2023).","journal-title":"J. Hepatol."},{"issue":"4","key":"66210_CR28","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","volume":"76","author":"R De Franchis","year":"2022","unstructured":"De Franchis, R., Bosch, J., Garcia-Tsao, G., Reiberger, T. & Ripoll, C. Baveno VII Faculty. Baveno VII\u2014Renewing consensus in portal hypertension. J. Hepatol. 76(4), 959\u2013974 (2022).","journal-title":"J. Hepatol."},{"issue":"11","key":"66210_CR29","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.14309\/ajg.0000000000000357","volume":"114","author":"R Harris","year":"2019","unstructured":"Harris, R., Card, T. R., Delahooke, T., Aithal, G. P. & Guha, I. N. Obesity ss the most common risk factor for chronic liver disease: Results from a risk stratification pathway using transient elastography. Am. J. Gastroenterol. 114(11), 1744\u20131752 (2019).","journal-title":"Am. J. Gastroenterol."},{"issue":"4","key":"66210_CR30","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/apt.14463","volume":"47","author":"DJ Harman","year":"2018","unstructured":"Harman, D. J. et al. Obesity and type 2 diabetes are important risk factors underlying previously undiagnosed cirrhosis in general practice: A cross-sectional study using transient elastography. Aliment Pharmacol. Ther. 47(4), 504\u2013515 (2018).","journal-title":"Aliment Pharmacol. Ther."},{"issue":"5","key":"66210_CR31","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/ajg.2016.453","volume":"112","author":"S McPherson","year":"2017","unstructured":"McPherson, S. et al. Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis. Am. J. Gastroenterol. 112(5), 740\u2013751 (2017).","journal-title":"Am. J. Gastroenterol."},{"key":"66210_CR32","unstructured":"European Association for the Study of the Liver. European Association for the Study of the Liver. EASL Clinical Practice Guidelines. Management of hepatocellular carcinoma. J. Hepatol. 2018;69(1):182\u2013236."},{"issue":"5","key":"66210_CR33","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.jhep.2020.06.007","volume":"73","author":"H Hagstr\u00f6m","year":"2020","unstructured":"Hagstr\u00f6m, H., Talb\u00e4ck, M., Andreasson, A., Walldius, G. & Hammar, N. Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease. J. Hepatol. 73(5), 1023\u20131029 (2020).","journal-title":"J. Hepatol."},{"issue":"2","key":"66210_CR34","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jhep.2023.04.002","volume":"79","author":"M Kjaergaard","year":"2023","unstructured":"Kjaergaard, M. et al. Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease. J. Hepatol. 79(2), 277\u2013286 (2023).","journal-title":"J. Hepatol."},{"issue":"2","key":"66210_CR35","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jhep.2019.03.033","volume":"71","author":"A Srivastava","year":"2019","unstructured":"Srivastava, A. et al. Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease. J. Hepatol. 71(2), 371\u2013378 (2019).","journal-title":"J. Hepatol."},{"issue":"1","key":"66210_CR36","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1186\/s12889-022-13724-6","volume":"22","author":"I Graupera","year":"2022","unstructured":"Graupera, I. et al. Liverscreen Consortium invertigators. LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries. BMC Public Health. 22(1), 1385 (2022).","journal-title":"BMC Public Health."},{"issue":"7","key":"66210_CR37","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S2468-1253(18)30077-3","volume":"3","author":"EA Tsochatzis","year":"2018","unstructured":"Tsochatzis, E. A. & Newsome, P. N. Non-alcoholic fatty liver disease and the interface between primary and secondary care. Lancet Gastroenterol. Hepatol. 3(7), 509\u2013517 (2018).","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"1","key":"66210_CR38","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/hep.29113","volume":"66","author":"A Unalp-Arida","year":"2017","unstructured":"Unalp-Arida, A. & Ruhl, C. E. Liver fibrosis scores predict liver disease mortality in the United States population. Hepatology 66(1), 84\u201395 (2017).","journal-title":"Hepatology"},{"issue":"23","key":"66210_CR39","first-page":"00225","volume":"S0168\u20138278","author":"M Kjaergaard","year":"2023","unstructured":"Kjaergaard, M. et al. Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease. J. Hepatol. S0168\u20138278(23), 00225\u201300228 (2023).","journal-title":"J. Hepatol."},{"issue":"10","key":"66210_CR40","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","volume":"7","author":"AG Shah","year":"2009","unstructured":"Shah, A. G. et al. Nash Clinical Research Network. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 7(10), 1104\u201312 (2009).","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"4","key":"66210_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2021.101848","volume":"46","author":"CM Canivet","year":"2022","unstructured":"Canivet, C. M. et al. Awareness of chronic liver diseases, a comparison between diabetologists and general practitioners. Clin. Res. Hepatol. Gastroenterol. 46(4), 101848 (2022).","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"11","key":"66210_CR42","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1002\/hep4.1765","volume":"5","author":"SA Alqahtani","year":"2021","unstructured":"Alqahtani, S. A. et al. Poor awareness of liver disease among adults with NAFLD in the United States. Hepatol. Commun. 5(11), 1833\u20131847 (2021).","journal-title":"Hepatol. Commun."},{"issue":"4","key":"66210_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100293","volume":"3","author":"D Mansour","year":"2021","unstructured":"Mansour, D. et al. Embedding assessment of liver fibrosis into routine diabetic review in primary care. JHEP Rep. 3(4), 100293 (2021).","journal-title":"JHEP Rep."},{"issue":"1","key":"66210_CR44","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1186\/s12913-022-07808-7","volume":"22","author":"L Gracen","year":"2022","unstructured":"Gracen, L. et al. Implementing the right care in the right place at the right time for non-alcoholic fatty liver disease (NAFLD-RRR study): A study protocol for a community care pathway for people with type 2 diabetes. BMC Health Serv. Res. 22(1), 487 (2022).","journal-title":"BMC Health Serv. Res."},{"key":"66210_CR45","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/9780470114759.ch5","volume-title":"An Introduction to Categorical Data Analysis","author":"A Agresti","year":"2007","unstructured":"Agresti, A. Building and applying logistic regression models. In An Introduction to Categorical Data Analysis 137\u2013172 (Wiley, 2007)."},{"issue":"11","key":"66210_CR46","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1111\/liv.14198","volume":"39","author":"C Crossan","year":"2019","unstructured":"Crossan, C. et al. Referral pathways for patients with NAFLD based on non-invasive fibrosis tests: Diagnostic accuracy and cost analysis. Liver Int. 39(11), 2052\u20132060 (2019).","journal-title":"Liver Int."},{"issue":"5","key":"66210_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0251741","volume":"16","author":"SE Congly","year":"2021","unstructured":"Congly, S. E., Shaheen, A. A. & Swain, M. G. Modelling the cost effectiveness of non-alcoholic fatty liver disease risk stratification strategies in the community setting. PLoS ONE 16(5), e0251741 (2021).","journal-title":"PLoS ONE"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-66210-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-66210-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-66210-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T15:21:38Z","timestamp":1725549698000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-66210-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["66210"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-66210-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,5]]},"assertion":[{"value":"10 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20720"}}